RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

How can the process of validation, acceptance and use of animal-free innovative approaches to assess the safety of chemicals be facilitated?

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

The Interspecies website which helps researchers to reduce and refine the use of laboratory animals is transferred to the 3Rs database Programme of the 3Rs-Centre Utrecht Life Sciences (ULS) of Utr

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).

In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.

Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).

January 19 - 25 European Cervical Cancer Prevention Week.

In the Netherlands, there are 80 municipalities with a low vaccination coverage for one or more vaccinations. This is a decrease compared to last year when there were still 90 municipalities.